D. Rivera, S. Peters, O. Panagiotou, D. Shah, N. Kuderer, Chih-Yuan Hsu, S. Rubinstein, B. J. Lee, T. Choueiri, G. de Lima Lopes, P. Grivas, C. Painter, B. Rini, M. Thompson, Jonathan T Arcobello, Z. Bakouny, D. Doroshow, P. Egan, D. Farmakiotis, L. Fecher, C. Friese, M. Galsky, S. Goel, Shilpa Gupta, T. Halfdanarson, B. Halmos, J. Hawley, A. Khaki, Christopher A. Lemmon, Sanjay Mishra, A. Olszewski, N. Pennell, M. Puc, S. Revankar, L. Schapira, A. Schmidt, G. Schwartz, S. Shah, Julie T Wu, Z. Xie, Albert C Yeh, Huili Zhu, Y. Shyr, G. Lyman, J. Warner
Cancer discovery, 2020
In a large observational study in patients with COVID-19 and cancer, survival was not significantly influenced by receipt of COVID-19 treatments, except hydroxychloroquine plus any other treatment, which was associated with reduced survival.
Cited by 44 publications.
Field of study: Medicine